Polymer Capital Management (HK)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Polymer Capital Management (HK)'s LLY Position: Q3 2026 in Review
Polymer Capital Management (HK) reduced its Eli Lilly (LLY) stake by 52% in Q3 2026, selling an estimated $34.9M and leaving 27,000 shares worth $31.2M. The position accounts for 2.96% of the portfolio, ranked #5.
Polymer Capital Management (HK) first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $67.9M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Polymer Capital Management (HK) held 27,000 shares of Eli Lilly worth $31.2M as of Q3 2026.
- Polymer Capital Management (HK) sold 29,607 Eli Lilly shares in Q3 2026, an estimated $34.9M.
- Eli Lilly made up 2.96% of Polymer Capital Management (HK)'s portfolio in Q3 2026, its #5 holding.
- Polymer Capital Management (HK) first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
- Polymer Capital Management (HK)'s Eli Lilly position peaked at $67.9M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Polymer Capital Management (HK)'s 13F filing for Q3 2026, filed 13 Nov 2026.